comparison of attention bias modification with pharmacotherapy in Patients ?with obsessive compulsive disorder

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N85

Enrollment

Registered

2018-09-26

Start date

2018-03-21

Completion date

Unknown

Last updated

2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive Compulsive Disorder. Obsessive-compulsive disorder

Interventions

Intervention 1: Intervention group: We treat patients by drugs in first group. Intervention 2: Intervention group: We treat patients by attention bias modification (10 sessions of 30 minutes every thr

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Obsessive compulsive disorder based on DSMV Not having a medical disorder at the same time Not having a low level of consciousness Not having other psychiatric disorders like bipolar disorder Psychosis Depression Mental retardation

Exclusion criteria

Exclusion criteria: Not having patient satisfaction Not having patient cooperation There is an acute period of illness that we have to do another health care for the patient.

Design outcomes

Primary

Measure	Time frame
Severity of obsessive-compulsive symptoms. Timepoint: Before and after the meetings. Method of measurement: Clinical observation.;Bound attention. Timepoint: Before and after the meetings. Method of measurement: Clinical observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mostafa Nokani

Arak University of Medical Sciences

nokani@arakmu.ac.ir+98 863222003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026